Plasma leptin levels are related to body composition, sex, insulin levels and the A55V polymorphism of the UCP2 gene

International Journal of Obesity

Volumn 31, Issue 8, 2007, Pages 1311-1318

  Rance, K A ^a   Johnstone, A M ^a   Murison, S ^a   Duncan, J S ^a   Wood, S G ^a   Speakman, J R ^a,b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Body composition; Insulin; Leptin; UCP2 polymorphism

Indexed keywords

INSULIN; LEPTIN; UNCOUPLING PROTEIN 2;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MINERAL; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXON; FEMALE; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNITED KINGDOM; VARIANCE;

ADULT; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; ION CHANNELS; LEPTIN; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEX CHARACTERISTICS; THYROXINE; TRIIODOTHYRONINE;

EID: 34547488447     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803535     Document Type: Article

References (48)

1. Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homolog. Nature 1994; 372: 425-432.
2. Flatt PR, Bailey CJ, Kwasowski P, Swanstonflatt SK. Contribution of hyperphagia to the development of metabolic abnormalities in obese hyperglycemic (Ob/Ob) mice. Nutr Rep Int 1989; 40: 1207-1215.
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
4. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
5. Cone RD. The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 1999; 10: 211-216.
6. Ahima RS, Prabakaran D, Mantzoros C, Qu DQ, Lowell B, MaratosFlier E et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.
7. Berthoud HR. A new role for leptin as a direct satiety signal from the stomach. Am J Physiol-Regulat Integr Comp Physiol 2005; 288: R796-R797.
8. Saladin R, Devos P, Guerremillo M, Leturque A, Girard J, Staels B et al. Transient increase in obese gene-expression after food-intake or insulin administration. Nature 1995; 377: 527-529.
9. Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding - implications for energy homeostasis and neuroendocrine function. J Clin Invest 1998; 101: 1020-1027.
10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
11. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-3427.
12. Ozata M, Ozisik G, Bingol N, Corakci A, Gundogan MA. The effects of thyroid status on plasma leptin levels in women. J Endocrinol Investigat 1998; 21: 337-341.
13. Kumar MV, Scarpace PJ. Differential effects of retinoic acid on uncoupling protein-1 and leptin gene expression. J Endocrinol 1998; 157: 237-243.
14. Lee KN, Jeong IC, Lee SJ, Oh SH, Cho MY. Regulation of leptin gene expression by insulin and growth hormone in mouse adipocytes. Exp Mol Med 2001; 33: 234-239.
15. Tan JTT, Patel BK, Kaplan LM, Koenig JI, Hooi SC. Regulation of leptin expression and secretion by corticosteroids and insulin - implications for body weight. Endocrine 1998; 8: 85-92.
16. Rayner DV, Trayhurn P. Regulation of leptin production: sympathetic nervous system interactions. J Mol Med- 2001; 79: 8-20.
17. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001; 42: 743-750.
18. Brann DW, De Sevilla L, Zamorano PL, Mahesh VB. Regulation of leptin gene expression and secretion by steroid hormones. Steroids 1999; 64: 659-663.
19. Zhang HH, Kumar S, Barnett AH, Eggo MC. Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake. J Clin Endocrinol Metab 1999; 84: 2550-2556.
20. Chung WK, Belfi K, Chua M, Wiley J, Mackintosh R, Nicolson M et al. Heterozygosity for Lep(ob) or Lepr(db) affects body composition and leptin homeostasis in adult mice. Am J Physiol-Regulat Integr Compar Physiol 1998; 43: R985-R990.
21. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R et al. Partial leptin deficiency and human adiposity. Nature 2001; 414: 34-35.
22. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997; 82: 585-589.
23. Carlsson B, Ankarberg C, Rosberg S, Norjavaara E, AlbertssonWikland K, Carlsson LMS. Serum leptin concentrations in relation to pubertal development. Arch Dis Childhood 1997; 77: 396-400.
24. Liu C, Grossmann A, Bain S, Strachan M, Puerner D, Bailey C et al. Leptin stimulates cortical bone formation in obese (ob/ob) mice. J Bone Mineral Res 1997; 12: 50.
25. Perez C, Fernandez-Galaz C, Fernandez-Agullo T, Arribas C, Andres A, Ros M et al. Leptin impairs insulin signaling in rat adipocytes. Diabetes 2004; 53: 347-353.
26. varez-Aguilar C, Mondragon-Jimenez LI, Ramirez-Enriquez J, Gomez-Garcia A, Paniagua-Sierra R, Amato D. Hyperleptinemia as a risk factor in obesity-related hypertension. Med Clin (Barc) 2004; 123: 766-769.
27. Perusse L, Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G et al. The human obesity gene map: the 2004 update. Obes Res 2005; 13: 381-490.
28. Astrup A, Toubro S, Dalgaard LT, Urhammer SA, Sorensen TI, Pedersen O. Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord 1999; 23: 1030-1034.
29. Klannemark M, Orho M, Groop L. No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure. Eur J Endocrinol 1998; 139: 217-223.
30. Yu X, Jacobs Jr DR, Schreiner PJ, Gross MD, Steffes MW, Fornage M. The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study. Clin Chem 2005; 51: 1451-1456.
31. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178-183.
32. D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F et al. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004; 53: 1905-1910.
33. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E1-E7.
34. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del GS et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003; 52: 1280-1283.
35. Fritsche A, Thart LM, Dekker JM, Machicao F, Heine RJ, Haring HU et al. Variability in insulin secretion in carriers of a common-866G/A polymorphism in the promoter of UCP2 in non-diabetic subjects. Diabetes 2004; 53: A271.
36. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M et al. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 2004; 22: 97-102.
37. Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR. Factors influencing variation in basal metabolic rate include fatfree mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr 2005; 82: 941-948.
38. Marti A, Corbalan S, Forga L, Martinez-Gonzalez MA, Martinez JA. Higher obesity risk associated with the exon-8 insertion of the UCP2 gene in a Spanish case-control study. Nutrition 2004; 20: 498-501.
39. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 1998; 7: 1431-1435.
40. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type ii diabetes. Diabetologia 2001; 44: 946-965.
41. Cassell PG, Neverova M, Janmohamed S, Uwakwe N, Qureshi A, McCarthy MI et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 1999; 42: 688-692.
42. Ur E, Morash B, Wilkinson M. Nutrient and insulin regulate leptin gene expression in the hypothalamus. Diabetes 2001; 50: A373-A374.
43. Poitout V, Rouault C, Guerre-Millo M, Reach G. Does leptin regulate insulin secretion? Diabetes Metab 1998; 24: 321-326.
44. van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913-917.
45. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Internal Med 2004; 140: 992-1000.
46. Kristensen K, Pedersen SB, Richelsen B. Interactions between sex steroid hormones and leptin in women. Studies in vivo and in vitro. Int J Obes Relat Metab Disord 2000; 24: 1438-1444.
47. Langin D. The role of uncoupling protein 2 in the development of type 2 diabetes. Drugs Today 2003; 39: 287-295.
48. Maestrini S, Podesta F, Di Blasio AM, Savia G, Brunani A, Tagliaferri A et al. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest 2003; 26: 985-990.